Serum beta 2 microglobulin in multiple myeloma. A critical review
- 31 December 1987
- journal article
- editorial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (12) , 1829-1832
- https://doi.org/10.1016/0277-5379(87)90047-2
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Beta2 microglobulin in multiple myelomaAmerican Journal of Hematology, 1985
- The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosisBlood, 1985
- Prognostic relevance of cellular morphology in multiple myelomaBlood, 1984
- Prognostic factors in plasma cell myelomaEuropean Journal of Cancer and Clinical Oncology, 1983
- Human myeloma in vitro colony growth: interrelationships between drug sensitivity, cell kinetics, and patient survival durationBlood, 1983
- Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and stagingBritish Journal of Haematology, 1982
- Ploidy and proliferative characteristics in monoclonal gammopathiesBlood, 1982
- Pretreatment tumor mass, cell kinetics, and prognosis in multiple myelomaBlood, 1980
- Kappa and lambda light chain disease: survival rates and clinical manifestationsBlood, 1976
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975